SV2A PET显示在认知不损害的APOE ε4 / ε4同胞体中发生海马突触损失
Anniina Snellman1,2, Jouni Tuisku1, Mikko Koivumäki1,2
1Turku PET Centre, University of Turku, Turku, Finland.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|October 30, 2024
概括
具有APOE ε4/ε4基因型的健康个体显示海马突触密度降低. 这种突触损失在认知能力下降之前就能被检测出来,这表明阿尔茨海默病连续体的早期变化.
科学领域:
- 神经科学是一个神经科学.
- 放射学 放射学是一门学科.
- 遗传学 遗传学 是一个
背景情况:
- 在携带无脂蛋白E (APOE) ε4等位基因的健康个体中研究突触密度.
- 评估突触密度,粉样β (Aβ) 负担和认知功能之间的关系.
研究的目的:
- 使用[11C]UCB-J正子发射断层扫描 (PET) 在体内测量海马突触密度.
- 为了比较不同阿波利波蛋白E (APOE) 基因型 (ε4/ε4, ε3/ε4, ε3/ε3) 的突触密度.
- 检查突触密度,Aβ和认知能力在认知不受损的个体之间的关联.
主要方法:
- 利用[11C]UCB-J PET成像来评估46名健康成年人的突触密度,按APOE基因型分层.
- 使用ANOVA和线性模型分析海马 [11C]UCB-J标准化吸收值比率 (SUVRs).
- 采用斯皮尔曼相关性来研究突触密度,Aβ负载,海马体积和认知得分之间的关系.
主要成果:
- 在APOE组中观察到海马突触密度的显著差异 (PANOVA=0.016).
- 与APOE ε3/ε3载体相比,APOE ε4/ε4载体的海马突触密度较低 (p=0.013).
- 在海马突触密度和CERAD总得分,APCC得分或[11C]PiB吸收之间没有发现显著的相关性.
结论:
- 在体内测量海马突触密度是可行的健康的老年人使用[11C]UCB-J PET.
- 在认知无损的APOE ε4 / ε4载体中,海马突触损失明显,这表明早期的AD连续变化.
- 在患阿尔茨海默氏症高风险个体中,突触密度的改变先于临床症状.
关键词:
阿尔茨海默氏症的疾病是阿尔茨海默氏症.[11C]UCB-JJ的情况氨基βββββββββββββββββββββββββ亚脂蛋白 E 是一种非脂蛋白 E.生物标志物生物标志物认知 认知 认知在海马体内,海马体定子发射断层扫描 (PET).在临床前的临床前.突触密度 突触密度 突触密度突触囊泡 2A 突触囊泡 2A 是一个突触囊泡.更多相关视频
09:45Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
Published on: March 22, 2016
10.2K
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
14.8K
相关概念视频
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
